Zdrowie i gospodarka · 12/05/2008

FDA Announces Pilot Program for Pharmaceutical Name Submissions

The FDA is hosting a public meeting to discuss a concept paper outlining the logistics of a pilot program that will allow pharmaceutical companies to submit proposed names for review, with the goal of streamlining the review process and enabling more efficient data sharing with the FDA.